Cambridge Investment Research Advisors’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7M Buy
340,472
+33,981
+11% +$1.44M 0.03% 527
2026
Q1
$11.9M Buy
306,491
+40,592
+15% +$1.65M 0.03% 551
2025
Q4
$10.9M Buy
265,899
+5,084
+2% +$207K 0.03% 553
2025
Q3
$10.5M Buy
260,815
+20,035
+8% +$772K 0.03% 544
2025
Q2
$8.86M Buy
240,780
+26,940
+13% +$912K 0.03% 587
2025
Q1
$7.1M Buy
213,840
+66,220
+45% +$2.3M 0.02% 635
2024
Q4
$5.11M Buy
147,620
+82,705
+127% +$2.9M 0.02% 796
2024
Q3
$2.2M Buy
64,915
+12,759
+24% +$418K 0.01% 1279
2024
Q2
$1.68M Buy
52,156
+6,266
+14% +$195K 0.01% 1409
2024
Q1
$1.42M Buy
45,890
+8,431
+23% +$247K 0.01% 1484
2023
Q4
$1.04M Buy
+37,459
New +$979K ﹤0.01% 1633

Other funds holding RECS

Cambridge Investment Research Advisors's RECS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Columbia Research Enhanced Core ETF (RECS) stake by 11% in Q2 2026, buying an estimated $1.44M and bringing the position to 340,472 shares worth $14.7M. The position accounts for 0.03% of the portfolio, ranked #527.

Cambridge Investment Research Advisors first reported a position in RECS in Q4 2023 and has held it in 11 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Cambridge Investment Research Advisors held 340,472 shares of Columbia Research Enhanced Core ETF worth $14.7M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 33,981 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $1.44M.
  • Columbia Research Enhanced Core ETF made up 0.03% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #527 holding.
  • Cambridge Investment Research Advisors first reported a position in Columbia Research Enhanced Core ETF in Q4 2023 and has held it in 11 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.